New Laser-Like eye surgery device falls short – trial stopped early

NCT ID NCT05713253

Terminated Disease control Sponsor: Johnson & Johnson Surgical Vision, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a device called the ELITA System to reduce or eliminate nearsightedness (myopia) and astigmatism. It involved 96 adults aged 22 and older who received a lenticule removal procedure in one or both eyes. The trial was terminated early, so the planned results on safety and vision improvement are not fully available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ELITA System (a device for lenticule removal surgery)
What this could lead to: If successful, this could offer a new surgical option to correct nearsightedness and astigmatism, potentially reducing dependence on glasses or contacts.
What could go wrong: The trial was terminated early, so we don't have full safety and effectiveness data. As with any eye surgery, risks include infection, under- or over-correction, and vision changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTIGMATISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

astigmatism myopia refractive error

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

REFRACTIVE ERROR

Contacts and locations

Locations

Hoopes, Durrie, Rivera Research, LLC

Draper, Utah, 84020, United States
Stanford Eye Laser Center

Palo Alto, California, 94303, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.